Related Experiment Video
Updated: Feb 28, 2026

03:47
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
706
Prognostic Factors for Recovery of Patients After Surgery for Thoracic Spinal Tuberculosis
Yuan Yao1, Huiyu Zhang2, Minghan Liu1
1Department of Orthopedics, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
World Neurosurgery
|June 13, 2017
Summary
Surgery for thoracic spinal tuberculosis (TST) recovery is influenced by key factors. Non-paralysis, shorter symptom duration, and fewer involved vertebrae significantly improve outcomes for TST patients.
Area of Science:
- Orthopedics
- Infectious Diseases
- Neurosurgery
Background:
- Thoracic spinal tuberculosis (TST) is a severe condition requiring both chemotherapy and surgery.
- No prior studies have identified prognostic factors for TST surgical recovery.
Purpose of the Study:
- To identify significant prognostic factors influencing patient recovery after TST surgery.
- To guide clinical decision-making and improve surgical outcomes for TST.
Main Methods:
- Retrospective analysis of 237 TST patients undergoing surgery (2001-2016).
- Japanese Orthopedic Association (JOA) score for recovery assessment.
- Kaplan-Meier and Cox regression analyses for prognostic factor identification.
Main Results:
- Univariate analysis identified diabetes, paralysis, kyphosis, symptom duration (>3 months), and vertebral involvement (>2) as potential factors.
- Multivariate analysis confirmed paralysis, symptom duration (≥3 months), and number of involved vertebrae (>2) as significant negative prognostic factors.
Conclusions:
- Non-paralysis, shorter symptom duration, and fewer involved vertebrae are favorable prognostic indicators for TST surgical recovery.
- Timely diagnosis and treatment are crucial for optimal recovery.
- Increased public awareness and government attention to spinal tuberculosis are urgently needed.
Related Concept Videos
Pneumothorax-II
1.2K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.2K
Pulmonary Tuberculosis V
691
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
691
Pulmonary Tuberculosis IV
575
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K